Applied DNA Sciences, Inc.
APDN · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $12 | $8 | $28 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $12 | $8 | $28 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -74.3% | -26.4% | 101.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 29.6% | 41.4% | 27.8% | 54.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -388.4% | -71.7% | -69.8% | -129.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -203.8% | -74.4% | -46.1% | -177.6% |
| EPS Diluted | -1.82 | -15.21 | -18.68 | -46.35 |
| % Growth | 88% | 18.6% | 59.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |